We sat down with Daniel Paull, JAX's new VP of discovery and platform development, to talk about the JAX-NYSCF Collaborative, the importance of induced pluripotent stem cells, the future of precision medicine, and more. 🧬 🔬
go.jax.org/Paull5Q
Q&A | Scaling discovery: How iPSCs, automation, and AI are shaping the future of disease research
Daniel Paull, who joins JAX from NYSCF as the vice president of discovery and platform development, has spent his career at the intersection of biology and engineering
